Archive for the ‘Zika virus’ Category
The Strategic National Stockpile’s Unique Role in Zika Prevention
Wednesday, May 11th, 2016
The first thing that comes to mind when people think about the Strategic National Stockpile (SNS) is probably a big warehouse with lots of medicines and supplies. What many do not know is that even when the SNS does not have the specific medicines or supplies needed to combat a public health threat, SNS experts can play a key role in working with medical supply chain partners to locate and purchase products during an emergency response.
The involvement of the SNS in the Zika virus response is a perfect example of this little-known, but significant, role. Zika is spread to people primarily through the bite of an Aedes aegypti mosquito infected with Zika virus, although Aedes albopictus mosquitoes may also spread the virus. Recent outbreaks of Zika in the Americas, Caribbean, and Pacific Islands have coincided with increased reports of microcephaly and other birth defects as well as Guillain-Barré syndrome. As a result, the Centers for Disease Control and Prevention’s (CDC) response is focused on limiting the spread of Zika virus. Prevention is key for Zika control, because there is no vaccine or medicine for Zika virus. This is where the SNS comes in.
Controlling mosquito populations is key to prevention
During a public health emergency, CDC can deploy the SNS for medicines and supplies or can use SNS’ contracting abilities to access materials and services that can be used to prevent or treat diseases that threaten U.S. health security. Controlling the mosquito population and addressing other known routes of infection are important to limit the spread of Zika virus in U.S. territories. The SNS is providing immediate vector control services and preventive supplies for pregnant women to protect themselves from mosquito bites. Pregnant women are particularly vulnerable because they can pass Zika virus to their fetuses, which can cause microcephaly and other brain defects.
Before the Zika virus outbreak, the SNS did not stock or purchase medicines or supplies to respond to illnesses spread by mosquitoes, ticks, and other insects. In response to this outbreak, SNS staff are working with CDC procurement experts to award and implement immediate, short-term contracts to deploy materials and services to control the mosquito populations responsible for Zika transmission. These contracts allow CDC to work with territorial public health jurisdictions to treat areas where mosquitoes breed and live, as well as areas where pregnant women live.
Zika Prevention Kits help pregnant women protect themselves
The SNS is creating Zika Prevention Kits for pregnant women in U.S. territories. These kits are being distributed as an effort to help prevent Zika infection in pregnant women and to reduce the number of babies born with birth defects caused by Zika, such as microcephaly and other brain defects. Through donations from the CDC Foundation and its partners and by purchasing products, the SNS has obtained materials for the kits – including insect repellent, larvicides, mosquito netting, condoms to prevent sexual transmission of Zika, and educational materials. The SNS is rapidly assembling these materials in reusable bags that can be given to pregnant women.
The SNS has sent nearly 7,000 kits to affected areas, and more are planned. Each U.S. territory is identifying the best way to get the kits to pregnant women. In Puerto Rico, local public health officials have partnered with clinics that are part of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) so they can reach expectant mothers. WIC already interacts with this population through its healthcare and nutritional services for low-income women, infants, and children. Local obstetrician offices are also being used to distribute these kits.
In the past, the SNS primarily focused on warehousing products and deploying those products for public health threats related to bioterrorism, pandemics, and natural disasters. With every emergency response, it has become more evident that the SNS can play a much larger role, especially when specialty products, products in high demand, and medical countermeasures are needed to secure the nation’s health. As one of the federal government’s leading groups of medical supply chain and logistics experts, the SNS at CDC has the ability to coordinate with industry partners to rapidly procure and transport medicines and supplies and serve specific populations in a public health emergency.
Posted on May 9, 2016 by
Zika Virus: Peru reports 9 imported cases, 4 locally acquired infections (including the sexual transmission case from Lima), and 3 that are under investigation.
Wednesday, May 4th, 2016CDC: Protecting Workers from Occupational Exposure to Zika Virus
Wednesday, May 4th, 2016CDC and OSHA Issue Interim Guidance for Protecting Workers from Occupational Exposure to Zika Virus
For Immediate Release: Friday, April 22, 2016
Contact: Media Relations,
(404) 639-3286
The Centers for Disease Control and Prevention (CDC) and the Occupational Safety and Health Administration (OSHA) today issued new guidance and information for protecting workers from occupational exposure to Zika virus.
- Interim guidance for outdoor workers, healthcare and laboratory workers, mosquito control workers, and business travelers to protect against occupational exposure to Zika virus
- Interim guidance and recommendations for employers to use to protect their workers
- Interim guidance and recommendations for workers to consider to protect themselves from mosquito bites and exposure to an infected person’s blood or other body fluids
CDC will continue to update this guidance as new information related to Zika virus transmission and related health effects becomes available, based on the accumulating evidence, expert opinion, and knowledge about the risk associated with other viral infections. Please visit http://www.cdc.gov/zika/vector/index.html for the most updated maps showing the approximate and potential locations of the two species of mosquitoes that are associated with Zika transmission.
Background:
Zika virus is primarily spread through the bites of infected mosquitoes. There is no vaccine to prevent Zika virus infection, and there is no specific treatment for people who become infected. Although Zika virus is primarily spread by infected mosquitoes, exposure to an infected person’s blood or other body fluids may also result in transmission. Outdoor workers may be at the greatest risk of exposure to Zika virus. Some workers, including those working with insecticides in areas of active Zika transmission to control mosquitoes and healthcare workers who may be exposed to contaminated blood or other potentially infectious materials from people infected with Zika virus, may require additional protection. Although there are no reports of transmission of Zika virus from infected patients to health care personnel or other patients, minimizing exposure to body fluids is important to reduce the possibility of such transmission. CDC has previously recommended Standard Precautions in all health care settings to protect both health care personnel and patients from infection with Zika virus as well as from blood-borne pathogens (e.g., human immunodeficiency virus [HIV] and hepatitis C virus [HCV]).
Outdoor workers
Recommended employer actions
- Inform workers about their risks of exposure to Zika virus through mosquito bites and train them how to protect themselves.
- Visit the CDC Zika website frequently for the most updated information.
- Provide insect repellents containing EPA-registered active ingredients and encourage their use.
- Provide workers with, and encourage them to wear, clothing that covers their hands, arms, legs, and other exposed skin. Consider providing workers with hats with mosquito netting to protect the face and neck.
- In warm weather, encourage workers to wear lightweight, loose-fitting clothing that covers exposed skin. This type of clothing protects workers against the sun’s harmful rays and provides a barrier to mosquitoes. Always provide workers with adequate water, rest, and shade, and monitor workers for signs and symptoms of heat illness.
- Get rid of sources of standing water (e.g., tires, buckets, cans, bottles, barrels) whenever possible to reduce or eliminate areas where mosquitoes can lay eggs. Train workers about the importance of eliminating standing water at the worksite.
- If requested by a worker, consider reassigning workers who indicate they are or may become pregnant, or male workers who have a sexual partner who is or may become pregnant, to indoor tasks to reduce their risk of mosquito bites.
Recommended worker actions
- Use insect repellents containing EPA-registered active ingredients.
- Wear clothing that covers hands, arms, legs, and other exposed skin. Wear hats with mosquito netting to protect the face and neck. Wear socks that cover the ankles and lower legs.
- In warm weather, wear lightweight, loose-fitting clothing that covers exposed skin. This type of clothing protects workers against the sun’s harmful rays and provides a barrier to mosquitoes. Drink plenty of water, take rest breaks in shaded areas, and watch for signs and symptoms of heat illness, including in coworkers.
- Get rid of sources of standing water (e.g., tires, buckets, cans, bottles, barrels) whenever possible to reduce or eliminate areas where mosquitoes can lay eggs.
- CDC recommends special precautions for pregnant women in areas with Zika transmission. Talk to your supervisor(s) about outdoor work assignment(s) if you are or may become pregnant, or, for male workers, if your sexual partner is or may become pregnant. Additional CDC information on Zika virus and pregnancy can be found on CDC’s website.
- If symptoms develop, seek medical attention promptly. Discuss any possible exposure to mosquitoes or infections spread by mosquitoes with a healthcare provider.
Healthcare and laboratory workers
- Employers and workers in healthcare settings and laboratories should follow standard infection control and biosafety practices (including universal precautions) as appropriate, to prevent or minimize the risk of Zika virus transmission.
- Standard precautions include, but are not limited to, hand hygiene and the use of PPE to avoid direct contact with blood and other potentially infectious materials, including laboratory specimens/samples. PPE may include gloves, gowns, masks, and eye protection.
- Hand hygiene consists of washing with soap and water or using alcohol-based hand rubs containing at least 60 percent alcohol. Soap and water are best for hands that are visibly soiled. Perform hand hygiene before and after any contact with a patient, after any contact with potentially infectious material, and before putting on and upon removing PPE, including gloves.
- Laboratories should ensure that their facilities and practices meet the appropriate Biosafety Level (BSL) for the type of work being conducted (including the specific biologic agents – in this case, Zika virus) in the laboratory.
- Employers should ensure that workers: Follow workplace standard operating procedures (e.g., workplace exposure control plans) and use the engineering controls and work practices available in the workplace to prevent exposure to blood or other potentially infectious materials.
- Employers should ensure workers do NOT bend, recap, or remove contaminated needles or other contaminated sharps. Properly dispose of these items in closable, puncture-resistant, leak-proof, and labeled or color-coded containers. Workers should use sharps with engineered sharps injury protection (SESIP) to avoid sharps-related injuries.
Mosquito control workers
- When working outdoors, follow the same precautions recommended above for general outdoor workers for protection against mosquito bites. Workers performing tasks related to mosquito control, such as entering areas with dense mosquito populations (ponds and other locations of standing water), may need additional protection (additional protective clothing, enhanced skin protection), depending on their job tasks.
- Workers who mix, load, apply, or perform other tasks involving wide-area (or area) insecticides may need additional protection to prevent or reduce exposure to hazardous chemicals.
- Workers conducting mosquito control operations with insecticides may require respirators, which must be used in accordance with the respirator selection, medical clearance, fit-testing, and other requirements of OSHA’s Respiratory Protection standard.
Business Travelers
- Follow CDC guidance for travel to areas with active Zika transmission
- Employers should consider allowing flexibility in required travel to areas with active Zika transmission for workers who are concerned about Zika virus exposure.
- CDC recommends that pregnant women not travel to areas with active Zika virus transmission.
- Consider delaying travel to areas with active Zika virus transmission, especially for workers who are or may become pregnant or whose sexual partners may become pregnant.
- Even if they do not feel sick, travelers returning to the United States from an area with Zika should take steps to prevent mosquito bites for 3 weeks so they do not pass Zika to mosquitoes that could spread the virus to other people.
CDC will continue to update its guidance related to occupational exposure to Zika and related health effects based on the accumulating evidence, expert opinion, and knowledge about the risk associated with other viral infections. For updates, visit: www.cdc.gov/zika
###
Mapping Zika Virus now and in the future: More than 2.17 billon people live in tropical and subtropical regions of the world that are suitable for Zika virus spread.
Sunday, April 24th, 2016Latest research on a possibly new Zika reservoir: Sera and oral swabs from 15 marmosets (Callithrix jacchus) and 9 capuchin-monkeys (Sapajus libidinosus) captured in Brazil tested positive for Zika virus.
Sunday, April 24th, 2016Are monkeys in Brazil a new reservoir for Zika Virus?
First detection of Zika virus in neotropical primates in Brazil: a possible new reservoir.
** NEJM: Zika Virus Review
Saturday, April 23rd, 2016(DOI: 10.1056/NEJMra1602113)
Zika virus is rapidly spreading throughout the Americas and the Caribbean. The association with microcephaly has led the WHO to declare a public health emergency. This review describes our current understanding of the characteristics of Zika virus infection.
Papua New Guinea: 6 cases of Zika virus infection
Saturday, April 23rd, 2016Zika virus infection – Papua New Guinea
On 11 March 2016, the National Department of Health of Papua New Guinea reported that 6 cases of Zika virus infection had been confirmed through retrospective testing of samples taken from patients presenting with a febrile illness between July 2014 and March 2016. Cases were confirmed by polymerase chain reaction (PCR). The following are the results by year:
- no Zika virus positive results were identified among 64 samples tested in 2014,
- 1 sample collected during a malaria outbreak in Morobe in May 2015 (a total of 34 samples were tested),
- 2 samples collected during a dengue outbreak in Western province in December 2015 (a total of 21 samples were tested), and
- 3 samples collected during a dengue outbreak in Kiunga in February 2016 (a total of 60 samples were tested).
None of the patients positive for Zika virus had travelled outside Papua New Guinea prior to their illness.
Martinique: Two cases of Zika-encephalopathy
Friday, April 22nd, 2016
Case 1
At the end of February 2016, two months after the detection of the first Zika virus-positive cases on Martinique, a previously healthy young adult was admitted to the University Hospital of Martinique, after having experienced an episode of convulsive seizures that occurred six hours after the onset of a dengue-like syndrome (fever, arthralgia, asthenia and headache). Upon initial clinical evaluation, the patient was febrile, with a low level of consciousness (Glasgow coma scale (GCS) 9) and no neurological focal signs. After direct intravenous injection of clonazepam (one milligram), the patient recovered to a normal level of consciousness (GCS 15). The patient was hospitalised for three days, then returned back home with symptomatic treatment of acetaminophen and codeine against headache and arthralgia. One week later, clinical assessment found no new neurological symptoms, but headache and arthralgia persisted for 45 days.
Brain magnetic resonance imaging (MRI) and video-electroencephalogram (EEG) performed on day 5 after onset of neurological symptoms, were normal.
Laboratory findings at onset of neurological symptoms showed normal blood count and a sterile CSF with no white blood cells (norm: < 10/ml), and 0.20 g/L protein (norm: 0.15–0.40). The glycorachia/glycaemia ratio was normal (norm: >0.5).
The patient was screened for the common aetiologies of viral encephalitis: test results for herpes simplex virus, varicella zoster virus and cytomegalovirus (CMV) by PCR were negative in CSF. Direct detection in CSF of enterovirus, dengue virus (DENV) and chikungunya virus by real-time RT-PCR were negative. Serological tests for HIV, CMV and venereal research disease laboratory (VDRL) were negative. Serology for toxoplasmosis was positive in IgG. Direct detection of Leptospira sp. in plasma by PCR was negative. Cryptococcus sp. antigenemia in serum was negative. Detection of Zika virus by real-time RT-PCR in plasma, cerebrospinal fluid and urine were positive.
Case 2
In the last week of February 2016, a patient in their late 70s was brought to the University Hospital of Martinique by their family who reported symptoms including acute mental confusion, speech disorder, and right facial palsy, which had started three hours before hospital admission. Upon initial clinical evaluation the patient was afebrile and aphasic; conjunctivitis, bilateral hands oedema, and peripheral arthritis were present. Facial palsy was not noticed upon clinical examination. Aphasia resolved spontaneously 45 minutes after the first clinical evaluation.
Upon initial clinical evaluation, brain MRI was only consistent with leukoaraiosis, and EEG revealed an unequivocal asymmetry with abnormal left fronto-temporal slow waves. These waves were consistent with the presence of a pathological process, but had no specific pattern. The EEG performed one week later showed almost complete regression of the slow waves.
The analysis of CSF showed a protein count of 0.40 g/L and a white blood cell count of 2/mL. The glycorachia/glycaemia ratio was normal. PCR for common aetiologies of encephalitis was negative. Detection of Zika virus by real-time RT-PCR in plasma, CSF and urine gave a positive result.”
Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil
Thursday, April 21st, 2016Wednesday, April 20th, 2016
City of New Orleans Develops Comprehensive Plan to Address Zika Virus
April 18, 2016
NEW ORLEANS – Today, the City of New Orleans announced that the New Orleans Health Department (NOHD) and the New Orleans Mosquito, Termite and Rodent Control Board (NOMTCB) developed a comprehensive plan to provide direction for the prevention and mitigation of Zika virus in Orleans Parish. Zika virus is most commonly transmitted to people through the bite of a Zika virus infected mosquito. At this time, there are no locally transmitted cases of the Zika virus in New Orleans. Four travel-related cases of Zika virus have been identified in Louisiana.
Click here to see the Zika Virus plan.
“We take the public health threat posed by the Zika virus very seriously,” said Mayor Mitch Landrieu. “We proactively put this plan in place to ensure that we are prepared and coordinated in the event of Zika transmission in New Orleans. Residents are highly encouraged to do their part to protect themselves and their loved ones from mosquitos.”
The Comprehensive Zika Plan was developed to guide coordination among various departments and identify preparedness and response initiatives to be taken in the city. These actions rely on the collaboration of several agencies including NOHD, NOMTCB, Louisiana Department of Health & Hospitals (DHH), the Centers for Disease Control and Prevention (CDC), Tulane University School of Public Health & Tropical Medicine, and the Louisiana Mosquito Control Association.
The plan outlines Zika virus management in three phases: no reported cases, travel-related cases and local transmission. Within each phase, the components of mosquito control, public education & media outreach, and interagency coordination are addressed. The plan is a living document subject to change and includes potential actions that may be taken. However, the level of implementation depends on the number of cases.
Moving forward, NOMTCB and NOHD will continue to coordinate with key partners to provide information about the Zika virus to the public.
NOMTCB has initiated its 2016 mosquito surveillance program which is monitoring the two mosquito species that are the primary carriers of Zika virus, the Yellow Fever mosquito and the Asian Tiger mosquito. NOMTCB uses an integrated mosquito management approach which includes mosquito population surveillance, public education, source reduction, eliminating mosquito breeding sites, biological control and pesticides when appropriate. Spray trucks and airplane spraying will be used if needed.
Mosquitos breed in standing water. Residents are encouraged to assist in reducing mosquito populations around their homes and businesses by removing trash and clutter; disposing of discarded tires and containers that can hold water; and turning over wading pools, buckets, trash cans, children’s toys or anything that could collect water.
Click here to download a factsheet on the Zika virus
About Zika Virus
Zika virus is transmitted to people through the bite of an infected mosquito. One in five people infected may develop symptoms, which include fever, rash, joint pain, muscle pain, headache and red eyes. Symptoms usually begin 3-7 days after being bitten by an infected mosquito. The illness can cause mild symptoms lasting up to a week.
At this time, there is no vaccine to prevent Zika virus infection, nor any specific medicine to treat it.
If diagnosed with Zika virus, you are urged to protect yourself from mosquito bites. If a mosquito bites you, it can spread the virus and infect others. ZIka can also be spread through sexual contact. If you have have been exposed to Zika you should use condoms or abstain from sexual activity for at least eight weeks. If infection is suspected, travel history should be shared with the healthcare provider.
The CDC recommends treating the symptoms by resting, drinking fluids and taking certain types of pain medicine. Click here for more information .
Zika virus can be spread from a mother to her fetus during pregnancy. Zika can cause a number of a number of health concerns during pregnancy including Microcephaly. Microcephaly is a birth defect that causes a baby’s head to be smaller as compared to other babies that are the same sex and age. Babies with Microcephaly often have smaller brains that might not have developed properly. There is no treatment to correct Microcephaly.
CDC Travel Alert
On Jan. 15, 2016, the CDC issued a travel alert for people traveling to regions where Zika virus transmission is ongoing.
Click here for a list of affected countries .
Pregnant women in any trimester should consider postponing travel to the areas where Zika virus transmission is ongoing. If you must travel to one of the areas, talk to your doctor first and strictly follow steps to prevent mosquito bites during the trip. It is safe for pregnant and breastfeeding women to use insect repellent.
SAFETY TIPS
Protecting Yourself
- Reduce mosquito exposure by limiting outdoor activities between dusk and dawn.
- Use air-conditioning and make sure window and door screens are in good repair to prevent mosquitoes from getting inside.
- If outside for long periods of time, wear long-sleeved shirts and pants.
- The CDC recommends using repellents containing EPA-registered active ingredients including DEET, picaridin, IR3535 or oil of lemon-eucalyptus.
- When using repellent, always follow the recommendations on the product label.
Protecting Your Home and Business
- Eliminate standing water around your home, where mosquitoes breed.
- Remove trash and clutter, dispose of discarded tires and containers that can hold water. Turn over wading pools, buckets, trash cans, children’s toys or anything that could collect water.
- Change water weekly in containers that cannot be removed, such as pet dishes or bird baths. Scrub the side of the containers each week to remove the eggs that have been deposited.
- Rain barrels and other water collection devices must be screened and collected water should be used within one week.
- Aerate ornamental pools, fountains and sugar kettles or stock them with fish.
- Report illegal dumping, water leaks and unattended swimming pools and by calling 311.
- Call 311 or email mosquitocontrol@nola.gov to report mosquito problems.
Tires are easily filled with water by rain and collect leaf litter, providing an ideal breeding site for mosquito larvae. Eliminating scrap tire dumps will eliminate a prolific mosquito habitat.
- Residents can place up to four tires weekly, stacked curbside along with their household trash.
- Tires in front of abandoned lots will not be collected; they must be moved in front of a residence with curbside collection.
- Residents can also bring up to four tires to the City’s Recycling Drop-off Center on the second Saturday of each month, which is located at 2829 Elysian Fields Avenue between 8 a.m. and 1 p.m.
Click here for more information on Household Item Recycling .
###